|
1
|
Lemjabbar-Alaoui H, Hassan OU, Yang YW and
Buchanan P: Lung cancer: Biology and treatment options. Biochim
Biophys Acta. 1856:189–210. 2015.PubMed/NCBI
|
|
2
|
Joshi BH, Hogaboam C, Dover P, Husain SR
and Puri RK: Role of interleukin-13 in cancer, pulmonary fibrosis,
and other TH2-type diseases. Vitam Horm. 74:479–504.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhu Z, Homer RJ, Wang Z, Chen Q, Geba GP,
Wang J, Zhang Y and Elias JA: Pulmonary expression of
interleukin-13 causes inflammation, mucus hypersecretion,
subepithelial fibrosis, physiologic abnormalities, and eotaxin
production. J Clin Invest. 103:779–788. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fujisawa T, Joshi B, Nakajima A and Puri
RK: A novel role of interleukin-13 receptor alpha2 in pancreatic
cancer invasion and metastasis. Cancer Res. 69:8678–8685. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fujisawa T, Joshi BH and Puri RK: IL-13
regulates cancer invasion and metastasis through IL-13Rα2 via
ERK/AP-1 pathway in mouse model of human ovarian cancer. Int J
Cancer. 131:344–356. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jakubzick C, Kunkel SL, Joshi BH, Puri RK
and Hogaboam CM: Interleukin-13 fusion cytotoxin arrests
Schistosoma mansoni egg-induced pulmonary granuloma formation in
mice. Am J Pathol. 161:1283–1297. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shimamura T, Fujisawa T, Husain SR, Joshi
B and Puri RK: Interleukin 13 mediates signal transduction through
interleukin 13 receptor alpha2 in pancreatic ductal adenocarcinoma:
Role of IL-13 Pseudomonas exotoxin in pancreatic cancer
therapy. Clin Cancer Res. 16:577–586. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Erkeland SJ, Valkhof M,
Heijmans-Antonissen C, Delwel R, Valk PJ, Hermans MH and Touw IP:
The gene encoding the transcriptional regulator Yin Yang 1 (YY1) is
a myeloid transforming gene interfering with neutrophilic
differentiation. Blood. 101:1111–1117. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hsu KW, Hsieh RH, Lee YH, Chao CH, Wu KJ,
Tseng MJ and Yeh TS: The activated Notch1 receptor cooperates with
alpha-enolase and MBP-1 in modulating c-myc activity. Mol
Cell Biol. 28:4829–4842. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Grehan JF, Levay-Young BK, Fogelson JL,
François-Bongarçon V, Benson BA and Dalmasso AP: IL-4 and IL-13
induce protection of porcine endothelial cells from killing by
human complement and from apoptosis through activation of a
phosphatidylinositide 3-kinase/Akt pathway. J Immunol.
175:1903–1910. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Moriya C, Jinnin M, Yamane K, Maruo K,
Muchemwa FC, Igata T, Makino T, Fukushima S and Ihn H: Expression
of matrix metalloproteinase-13 is controlled by IL-13 via PI3K/Akt3
and PKC-delta in normal human dermal fibroblasts. J Invest
Dermatol. 131:655–661. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Petrella BL and Brinckerhoff CE: PTEN
suppression of YY1 induces HIF-2 activity in von-Hippel-Lindau-null
renal-cell carcinoma. Cancer Biol Ther. 8:1389–1401. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Guo J, Yao H, Lin X, Xu H, Dean D, Zhu Z,
Liu G and Sime P: IL-13 induces YY1 through the AKT pathway in lung
fibroblasts. PLoS One. 10:e01190392015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lages E, Ipas H, Guttin A, Nesr H, Berger
F and Issartel JP: MicroRNAs: Molecular features and role in
cancer. Front Biosci. 17:2508–2540. 2012. View Article : Google Scholar
|
|
15
|
Larsen JE and Minnar JD: Molecular biology
of lung cancer: Clinical implications. Clin Chest Med. 32:703–740.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jin M, Wu Y, Wang Y, Yu D, Yang M, Yang F,
Feng C and Chen T: MicroRNA-29a promotes smooth muscle cell
differentiation from stem cells by targeting YY1. Stem Cell Res.
17:277–284. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang H, Garzon R, Sun H, Ladner KJ, Singh
R, Dahlman J, Cheng A, Hall BM, Qualman SJ, Chandler DS, et al:
NF-kappaB-YY1-miR-29 regulatory circuitry in skeletal myogenesis
and rhabdomyosarcoma. Cancer Cell. 14:369–381. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ebrahimi S, Hosseini M, Shahidsales S,
Maftouh M, Ferns GA, Ghayour-Mobarhan M, Hassanian SM and Avan A:
Targeting the Akt/PI3K signaling pathway as a potential therapeutic
strategy for the treatment of pancreatic cancer. Curr Med Chem.
24:1321–1331. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bahrami A, Khazaei M, Hasanzadeh M,
ShahidSales S, Mashhad Joudi M, Farazestanian M, Sadeghnia HR,
Rezayi M, Maftouh M, Hassanian SM and Avan A: Therapeutic potential
of targeting PI3K/AKT pathway in treatment of colorectal cancer:
Rational and progress. J Cell Biochem. 119:2460–2469. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Heavey S, O'Byrne KJ and Gately K:
Strategies for co-targeting the PI3K/AKT/mTOR pathway in NSCLC.
Cancer Treat Rev. 40:445–456. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tu M, Wange W, Cai L, Zhu P, Gao Z and
Zheng W: IL-13 receptor alpha2 stimulates human glioma cell growth
and metastasis through the Src/PI3K/Akt/mTOR signaling pathway.
Tumour Biol. 37:14701–14709. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Berns KI and Bohenzky RA: Adeno-associated
viruses: An update. Adv Virus Res. 32:243–306. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shi Y, Seto E, Chang LS and Shenk T:
Transcriptional repression by YY1, a human GLI-Kruppel-related
protein, and relief of repression by adenovirus E1A protein. Cell.
67:377–388. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Park K and Atchison ML: Isolation of a
candidate repressor/activator, NF-E1 (YY-1, delta), that binds to
the immunoglobulin kappa 3′ enhancer and the immunoglobulin
heavy-chain mu E1 site. Proc Natl Acad Sci USA. 88:9804–9808. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Diehl JA, Cheng M, Roussel MF and Sherr
CJ: Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis
and subcellular localization. Genes Dev. 12:3499–3511. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Graff JR, Konicek BW, McNulty AM, Wang Z,
Houck K, Allen S, Paul JD, Hbaiu A, Goode RG, Sandusky GE, et al:
Increased AKT activity contributes to prostate cancer progression
by dramatically accelerating prostate tumor growth and diminishing
p27Kip1 expression. J Biol Chem. 275:24500–24505. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Xu W, Yang Z and Lu N: A new role for the
PI3K/Akt signaling pathway in the epithelial-mesenchymal
transition. Cell Adh Migr. 9:317–324. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cicatiello L, Scafoglio C, Altucci L,
Cancemi M, Natoli G, Facchiano A, Iazzetti G, Calogero R, Biglia N,
De Bortoli M, et al: A genomic view of estrogen actions in human
breast cancer cells by expression profiling of the
hormone-responsive transcriptome. J Mol Endocrinol. 32:719–775.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sui G, Affar el B, Shi Y, Brignone C, Wall
NR, Yin P, Donohoe M, Luke MP, Calvo D, Grossman SR, et al: Yin
Yang 1 is a negative regulator of p53. Cell. 117:859–872. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Riggs KJ, Saleque S, Wong KK, Merrell KT,
Lee JS, Shi Y and Calame K: Yin-yang 1 activates the I promoter.
Mol Cell Biol. 13:7487–7495. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Vella P, Barozzi I, Cuomo A, Bonaldi T and
Pasini D: Yin Yang 1 extends the Myc-related transcription factors
network in embryonic stem cells. Nucleic Acids Res. 40:3403–3418.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lu SY, Rodriguez M and Liao WS: YY1
represses rat serum amyloid A1 gene transcription and is
antagonized by NF-kappa B during acute-phase response. Mol Cell
Biol. 14:6253–6263. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sepulveda MA, Emelyanov AV and Birshtein
BK: NF-kappa B and Oct-2 synergize to activate the human 3′ Igh hs4
enhancer in B cells. J Immunol. 172:1054–1064. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang H, Hertlein E, Bakkar N, Sun H,
Acharyya S, Wang J, Carathers M, Davuluri R and Guttridge DC:
NF-kappaB regulation of YY1 inhibits skeletal myogenesis through
transcriptional silencing of myofibrillar genes. Mol Cell Biol.
27:4374–4387. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Martínez-Paniagua MA, Baritaki S,
Huerta-Yepez S, Ortiz-Navarrete VF, González-Bonilla C, Bonavida B
and Vega MI: Mcl-1 and YY1 inhibition and induction of DR5 by the
BH3-mimetic Obatoclax (GX15-070) contribute in the sensitization of
B-NHL cells to TRAIL apoptosis. Cell Cycle. 10:2792–2805. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Reséndiz-Martínez J, Asbun-Bojalil J,
Huerta-Yepez S and Vega M: Correlation of the expression of YY1 and
Fas cell surface death receptor with apoptosis of peripheral blood
mononuclear cells, and the development of multiple organ
dysfunction in children with sepsis. Mol Med Rep. 15:2433–2442.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Naruse K, Lash GE, Innes BA, Otun HA,
Searle RF, Robson SC and Bulmer JN: Localization of matrix
metalloproteinase (MMP)-2, MMP-9 and tissue inhibitors for MMPs
(TIMPs) in uterine natural killer cells in early human pregnancy.
Hum Reprod. 24:553–561. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Tian FJ, Cheng YX, Li XC, Wang F, Qin CM,
Ma XL, Yang J and Lin Y: The YY1/MMP2 axis promotes trophoblast
invasion at the maternal-fetal interface. J Pathol. 239:36–47.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Fabbri M, Garzon R, Cimmino A, Liu Z,
Zanesi N, Callegari E, Liu S, Alder H, Costinean S,
Fernandez-Cymering C, et al: MicroRNA-29 family reverts aberrant
methylation in lung cancer by targeting DNA methyltransferases 3A
and 3B. Proc Natl Acad Sci USA. 104:15805–15810. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Hu Z, Cui Y, Zhou Y, Zhou K, Qiao X, Li C
and Wang S: MicroRNA-29a plays a suppressive role in non-small cell
lung cancer cells via targeting LASP1. Onco Targets Ther.
9:6999–7009. 2016. View Article : Google Scholar : PubMed/NCBI
|
